Compare Edgewise Therapeutics Inc. Common Stock (EWTX) vs Lemonade Inc (LMND) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edgewise Therapeutics Inc. Common Stock vs Lemonade Inc — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B), while Lemonade Inc trades at $42.48 (market cap $3.39B). The key difference: Edgewise Therapeutics Inc. Common Stock is the larger of the two by market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, Lemonade Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Lemonade Inc for 27 Days on average.
| EWTX | LMND | |
|---|---|---|
Market Cap | $4.02B | $3.39B |
Volume | 1,446,128 | 1,877,282 |
Sector | Health | Financials |
52-Week High | $48.35 | $96.57 |
52-Week Low | $14.89 | $43.86 |
Typical Hold Time | 0 Days | 27 Days |
Enterprise Value | $3.56B | $3.25B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Lemonade (LMND) trades at $44.71, down 0.97% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth from $257M in 2022 to $738M in 2025, though remains unprofitable with a -22.43% net margin. Analyst consensus is divided with a $67 price target, while technical indicators show oversold conditions with key support at $43.
Lemonade's path to profitability by late 2026 presents opportunity, but execution risks and persistent losses require caution. Expansion into new states and AI-driven efficiency improvements support growth, yet competitive pressures and cash flow challenges remain headwinds for investors seeking exposure to insurtech disruption.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →About Lemonade Inc
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →
